Currently, dry AMD management relies on lifestyle modifications such as smoking cessation and dietary supplementation, [14] while wet AMD is treated with intravitreal injections of vascular endothelial growth factor (VEGF) inhibitors, a key modulator of neovascularisation [15]. Here, VEGFA is linked to wet macular degeneration.